Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection

Wong, Li Ping and Lai, Lee Lee and See, Mee Hoong and Alias, Haridah and Syed Omar, Sharifah Faridah and Ng, Chong Guan and Ho, Gwo Fuang and Ong, Teng Aik and Wong, Yee Chi and Ooi, Po Lin and Elias, Jasmin Munchar and Hu, Zhijian and Lin, Yulan (2022) Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection. Frontiers in Psychology, 13. ISSN 1664-1078, DOI https://doi.org/10.3389/fpsyg.2022.906067.

Full text not available from this repository.

Abstract

PurposeThis study aims to describe the adverse events following immunization (AEFIs) of SARS-CoV-2 vaccination in cancer patients/survivors associated with their psychological distress. MethodsA cross-sectional study was conducted to assess AEFIs after the receipt of SARS-CoV-2 vaccines in cancer patients/survivors attending a university hospital in Malaysia. Psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS) before and after the first and second doses of COVID-19 vaccine. ResultsA total of 217 complete responses were received. Compared with before vaccination, both HADS Anxiety (HADS-A) and HADS Depression (HADS-D) scores were significantly reduced after the first and second dose of the SARS-CoV-2 vaccine. Most of the participants had mild-or-moderate systemic and local AEFIs, with the most common being pain at the injection site, tiredness, and headache for both the first and second doses of the vaccine. Positive correlations between the total AEFI score and HADS-A (r = 0.309, p < 0.001) and HADS-D (r = 0.214, p = 0.001) scores were observed after the first dose of the SARS-CoV-2 vaccine. Similarly, positive associations were observed between the total AEFI score and HADS-A (r = 0.305, p < 0.001) and HADS-D (r = 0.235, p < 0.001) scores after the second dose of the SARS-CoV-2 vaccine. ConclusionMild-to-moderate AEFIs found in this study help address vaccine hesitancy in cancer patients/survivors. Receiving the SARS-CoV-2 vaccine had a positive effect on decreasing psychological distress in cancer patients/survivors. High severity of an AEFI was associated with higher anxiety and depressive symptoms.

Item Type: Article
Funders: Special Projects of the Central Government Guiding Local Science and Technology Development, China, 2021L3018
Uncontrolled Keywords: Adverse events; Cancer survivors; COVID-19 vaccine; Anxiety; Depression
Subjects: B Philosophy. Psychology. Religion > BF Psychology
Divisions: Faculty of Medicine > Medicine Department
Faculty of Medicine > Social & Preventive Medicine
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 24 Nov 2023 02:55
Last Modified: 24 Nov 2023 02:55
URI: http://eprints.um.edu.my/id/eprint/41596

Actions (login required)

View Item View Item